No relation between docetaxel administration route and high‐grade diarrhea incidence-Reference-Cited by-同舟云学术

No relation between docetaxel administration route and high‐grade diarrhea incidence

Published:2020-07-28 Issue:4 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Hendrikx Jeroen J. M. A.¹²³^ORCID,Stuurman Frederik E.¹⁴,Song Ji‐Ying⁵,Weger Vincent A.¹⁴,Lagas Jurjen S.¹⁶,Rosing Hilde¹,Beijnen Jos H.¹⁷⁸,Schinkel Alfred H.²,Schellens Jan H. M.⁷⁸,Marchetti Serena⁴

Affiliation:

1. Department of Pharmacy & Pharmacology The Netherlands Cancer Institute Amsterdam The Netherlands

2. Division of Pharmacology The Netherlands Cancer Institute Amsterdam The Netherlands

3. Department of Nuclear Medicine The Netherlands Cancer Institute Amsterdam The Netherlands

4. Department of Clinical Pharmacology The Netherlands Cancer Institute Amsterdam The Netherlands

5. Department of Experimental Animal Pathology The Netherlands Cancer Institute Amsterdam The Netherlands

6. Diakonessenhuis Utrecht The Netherlands

7. Department of Pharmaceutical Sciences Utrecht University Utrecht The Netherlands

8. Modra Pharmaceuticals BV Amsterdam The Netherlands

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.633

Reference47 articles.

1. Preclinical Pharmacology of the Taxanes: Implications of the Differences

2. Taxanes: Old drugs, new oral formulations

3. Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel

4. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

5. Coadministration of Ritonavir Strongly Enhances the Apparent Oral Bioavailability of Docetaxel in Patients with Solid Tumors

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging;Biomaterials Advances;2024-06

2. Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity;Cancer Chemotherapy and Pharmacology;2024-05-11

3. Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment;Cancer Chemotherapy and Pharmacology;2024-03-08

4. Physiologically‐based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk;CPT: Pharmacometrics & Systems Pharmacology;2023-10-05

5. The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins;Biomedicine & Pharmacotherapy;2023-06